ArticleCancer research communications2024

The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors.

Caroline E Dravillas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.